Thanks for the link, so at 7min 40sec, Dr GK said this Lupin+veyonda study is a phase 2. I recall someone questioning that it is an investigator study so not even considered valid (something like that was said). So in FDA eyes, is it considered phase 2? Just wondering as it would mean Novartis and Noxopharm can technically start phase 3 studies?
- Forums
- ASX - By Stock
- NOX
- A GREAT interview by Peter Switzer
A GREAT interview by Peter Switzer, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
IGO
IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
Add NOX (ASX) to my watchlist
|
|||||
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.04M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 72463 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 8810 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 72463 | 0.069 |
3 | 22705 | 0.068 |
1 | 1672 | 0.066 |
1 | 15000 | 0.065 |
1 | 15626 | 0.064 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 8810 | 1 |
0.073 | 74991 | 2 |
0.074 | 50000 | 1 |
0.076 | 4999 | 1 |
0.079 | 12000 | 1 |
Last trade - 10.16am 29/07/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
Day chart unavailable